asthmatic
Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with       a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin       (PG)F1alpha.
Leukotriene (LT)-receptor antagonist is more effective in  @SUBJECT$  @PREDICAT$  @OBJECT$  with       a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin       (PG)F1alpha.